Bayer names new GM for therapeutics unit

Brenda L. Raphael will become Bayer’s senior vice president and general manager of the Therapeutics Business Unit of Consumer Health Commercial Operations North America beginning Oct. 30, the Whippany-based company announced.

“Brenda has more than 20 years of experience in leading successful billion-dollar, consumer-focused brands,” said Natalie Bartner, president of North America Consumer Health, Consumer Health Division, Bayer. “Her strengths in understanding customers, marketing and innovation will lead the Therapeutics Business Unit to continue developing self-care solutions that help people live healthier lives.”

Raphael was previously general manager for U.S. brands in Pharma at Pfizer Inc.’s New York City offices. She also previously held various senior positions at the Coca-Cola Co. and Procter & Gamble.

With experience that spans pharmaceuticals and consumer products, Raphael delivered significant financial gains to the businesses, and insight-driven multichannel marketing to consumers.

Raphael will report to Bartner, and will be a member of the Consumer Health North America Leadership Team.